A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease
一项评估基质金属蛋白酶-9抑制剂安德卡利昔单抗治疗中重度活动性克罗恩病患者的II期随机、安慰剂对照研究
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjy070
Schreiber, Stefan; Siegel, Corey A; Friedenberg, Keith A; Younes, Ziad H; Seidler, Ursula; Bhandari, Bal R; Wang, Ke; Wendt, Emily; McKevitt, Matt; Zhao, Sally; Sundy, John S; Lee, Scott D; Loftus, Edward V